Catalyst Wire Dossier Catalyst Wire Dossier

Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy

· Shanghai AbelZeta Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy, covering 2016-04-04 to 2016-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis [Phase 1, Phase 2]

See pricing